Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Short term Debt (2016 - 2023)

Historic Short term Debt for Arcadia Biosciences (RKDA) over the last 10 years, with Q1 2023 value amounting to $15000.0.

  • Arcadia Biosciences' Short term Debt fell 7826.09% to $15000.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $15000.0, marking a year-over-year decrease of 7826.09%. This contributed to the annual value of $48000.0 for FY2022, which is 2500.0% down from last year.
  • As of Q1 2023, Arcadia Biosciences' Short term Debt stood at $15000.0, which was down 7826.09% from $48000.0 recorded in Q4 2022.
  • In the past 5 years, Arcadia Biosciences' Short term Debt registered a high of $1.1 million during Q4 2020, and its lowest value of $12000.0 during Q1 2019.
  • Moreover, its 5-year median value for Short term Debt was $51000.0 (2021), whereas its average is $302235.3.
  • Examining YoY changes over the last 5 years, Arcadia Biosciences' Short term Debt showed a top increase of 703125.0% in 2021 and a maximum decrease of 9439.09% in 2021.
  • Arcadia Biosciences' Short term Debt (Quarter) stood at $40000.0 in 2019, then soared by 2752.5% to $1.1 million in 2020, then tumbled by 94.39% to $64000.0 in 2021, then dropped by 25.0% to $48000.0 in 2022, then plummeted by 68.75% to $15000.0 in 2023.
  • Its Short term Debt was $15000.0 in Q1 2023, compared to $48000.0 in Q4 2022 and $47000.0 in Q3 2022.